Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction …
Importance Worsening chronic heart failure (HF) is a major public health problem. Objective
To determine the optimal dose and tolerability of vericiguat, a soluble guanylate cyclase …
To determine the optimal dose and tolerability of vericiguat, a soluble guanylate cyclase …
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection …
M Gheorghiade, SJ Greene, J Butler, G Filippatos… - JAMA, 2015 - europepmc.org
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in
Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The …
Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The …
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection …
M Gheorghiade, SJ Greene, J Butler, G Filippatos… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Importance Worsening chronic heart failure (HF) is a major public health problem. Objective
To determine the optimal dose and tolerability of vericiguat, a soluble guanylate cyclase …
To determine the optimal dose and tolerability of vericiguat, a soluble guanylate cyclase …
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection …
M Gheorghiade, SJ Greene, J Butler… - JAMA: The Journal …, 2015 - research.regionh.dk
OBJECTIVE: To determine the optimal dose and tolerability of vericiguat, a soluble
guanylate cyclase stimulator, in patients with worsening chronic HF and reduced left …
guanylate cyclase stimulator, in patients with worsening chronic HF and reduced left …
Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction …
M Gheorghiade, SJ Greene, J Butler… - JAMA: the Journal of …, 2015 - zora.uzh.ch
IMPORTANCE: Worsening chronic heart failure (HF) is a major public health problem.
OBJECTIVE: To determine the optimal dose and tolerability of vericiguat, a soluble …
OBJECTIVE: To determine the optimal dose and tolerability of vericiguat, a soluble …
Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction
M Gheorghiade, SJ Greene, J Butler… - JAMA: Journal of the …, 2015 - eprints.gla.ac.uk
Importance: Worsening chronic heart failure (HF) is a major public health problem.
Objective: To determine the optimal dose and tolerability of vericiguat, a soluble guanylate …
Objective: To determine the optimal dose and tolerability of vericiguat, a soluble guanylate …
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection …
M Gheorghiade, SJ Greene, J Butler… - JAMA: The Journal of …, 2015 - pure.au.dk
OBJECTIVE: To determine the optimal dose and tolerability of vericiguat, a soluble
guanylate cyclase stimulator, in patients with worsening chronic HF and reduced left …
guanylate cyclase stimulator, in patients with worsening chronic HF and reduced left …
[PDF][PDF] Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced …
M Gheorghiade, SJ Greene, J Butler, G Filippatos… - 2015 - researchgate.net
OBJECTIVE To determine the optimal dose and tolerability of vericiguat, a soluble guanylate
cyclase stimulator, in patients with worsening chronic HF and reduced left ventricular …
cyclase stimulator, in patients with worsening chronic HF and reduced left ventricular …
Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients withworsening chronic heart failure and reduced ejection fraction …
M Gheorghiade, S Greene, J Butler, G Filippatos… - JAMA, 2015 - boa.unimib.it
IMPORTANCE Worsening chronic heart failure (HF) is a major public health problem.
OBJECTIVE To determine the optimal dose and tolerability of vericiguat, a soluble guanylate …
OBJECTIVE To determine the optimal dose and tolerability of vericiguat, a soluble guanylate …
[引用][C] Effect of Vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection …
F Martens - JAMA, 2015 - researchinformation.amsterdamumc …
Effect of Vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in
patients with worsening chronic heart failure and reduced ejection fraction: The Socrates-Reduced …
patients with worsening chronic heart failure and reduced ejection fraction: The Socrates-Reduced …